APA (7th ed.) Citation

Raczynska, D., Ernest, J., Baumane, K., Sagong, M., Akiyama, K., Rauschning, W., . . . Papp, A. (2026). Therapeutic Equivalence of Eyluxvi (Aflibercept) to Eylea in Neovascular Age-Related Macular Degeneration: ALTERA Trial (Randomized). Ophthalmology & Therapy, 15(2), 887. https://doi.org/10.1007/s40123-026-01321-4

Chicago Style (17th ed.) Citation

Raczynska, Dorota, et al. "Therapeutic Equivalence of Eyluxvi (Aflibercept) to Eylea in Neovascular Age-Related Macular Degeneration: ALTERA Trial (Randomized)." Ophthalmology & Therapy 15, no. 2 (2026): 887. https://doi.org/10.1007/s40123-026-01321-4.

MLA (9th ed.) Citation

Raczynska, Dorota, et al. "Therapeutic Equivalence of Eyluxvi (Aflibercept) to Eylea in Neovascular Age-Related Macular Degeneration: ALTERA Trial (Randomized)." Ophthalmology & Therapy, vol. 15, no. 2, 2026, p. 887, https://doi.org/10.1007/s40123-026-01321-4.